Ann: CEO Presentation to Bioshares Conference, page-2

First thoughts:

1. Healing curve (pg 7) remains very promising after the addition of another 22 patients.
2. I really like page 9 showing a history of deals in the wound space in the past decade. All deals show how dramatically undervalued FTT is at the moment.
3. Does page 10 mean a preliminary deal has been agreed pending results?!?!?

Anyone at the Bioshares presentation today that can provide context around what is said about page 10 would be greatly appreciated.